Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand?

Journal: Current oncology (Toronto, Ont.)
Published Date: Apr 20, 2023

Abstract

In 2018, the da Vinci Single Port (SP) robotic system was approved by the US Food and Drug Administration for urologic procedures. Available studies for the application of SP to prostate cancer surgery are limited. The aim of our study is to summarize the current evidence on the techniques and outcomes of SP robot-assisted radical prostatectomy (SP-RARLP) procedures. A narrative review of the literature was performed in January 2023. Preliminary results suggest that SP-RALP is safe and feasible, and it can offer comparable outcomes to the standard multiport RALP. Extraperitoneal and transvesical SP-RALP appear to be the two most promising approaches, as they offer decreased invasiveness, potentially shorter length of stay, and better pain control. Long-term, high-quality data are missing and further validation with prospective studies across different sites is required.

Authors

  • Antonio Franco
    Department of Urology, Rush University, Chicago, IL, USA.
  • Antony A Pellegrino
    Department of Urology, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Cosimo De Nunzio
    Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
  • Morgan Salkowski
    Department of Urology, Rush University, Chicago, IL 60612, USA.
  • Jamal C Jackson
    Department of Urology, Rush University, Chicago, IL 60612, USA.
  • Lucas B Zukowski
    Department of Urology, Rush University, Chicago, IL 60612, USA.
  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Srinivas Vourganti
    Rush University Medical Center, Chicago, Illinois.
  • Alexander K Chow
    School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Jihad Kaouk
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: kaoukj@ccf.org.
  • Simone Crivellaro
    Department of Urology, College of Medicine, University of Illinois at Chicago, 820 S Wood Street, Chicago, IL, 60612, USA.
  • Riccardo Autorino
    Department of Urology, Rush University, Chicago, IL, USA.

Keywords

External Resources

Popular Topics
Recent Journals